Patent · US Active

Substituted oxopyridine derivatives

US10421742B2 · kind B2 · utility

2Cited by

0References

9Claims

0Family size

Assignee

Bayer Pharma Aktiengesellschaft · DE

Inventors

Eloisa JIMENEZ NUNEZ · Wuppertal, DE
Jens Ackerstaff · Mülheim an der Ruhr, DE
Susanne Röhrig · Hilden, DE
Alexander Hillisch · Solingen, DE
Katharina MEIER · Mettmann, DE
Stefan Heitmeier · Wülfrath, DE
Adrian Tersteegen · Wuppertal, DE
Jan STAMPFUß · Mülheim an der Ruhr, DE
Pascal ELLERBROCK · Düsseldorf, DE
Daniel Meibom · Leverkusen, DE
Dieter Lang · Velbert, DE

Key dates

Filing date	Jul 5, 2016
Grant date	Sep 24, 2019
Priority date	—
Expiry date	Jul 5, 2036

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D413/14
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

The invention relates to substituted oxopyridine derivatives and to processes for their preparation, and also to their use for preparing medicaments for the treatment and/or prophylaxis of diseases, in particular cardiovascular disorders, preferably thrombotic or thromboembolic disorders, and oedemas, and also ophthalmic disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.